Cohort1: dose level 1
|
Administration route |
subretinal injection |
Dosage |
5E10 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
3/3(Sub-conjunctival haemorrhage) |
References |
PMID:
32094925
|
|
Cohort2: dose level 2
|
Administration route |
subretinal injection |
Dosage |
1E11 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
1/3(Anterior uveitis) |
References |
PMID:
32094925
|
|
Cohort3: dose level 3
|
Administration route |
subretinal injection |
Dosage |
5E11 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
3/3(Persistent subretinal fluid; Anterior uveitis; Suture related inflammation; Corneal abrasion) |
References |
PMID:
32094925
|
|
Cohort4: dose level 4
|
Administration route |
subretinal injection |
Dosage |
1E12 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
3/3(Anterior uveitis; subretinal inflammation) |
References |
PMID:
32094925
|
|
Cohort5: dose level 5
|
Administration route |
subretinal injection |
Dosage |
2.5E12 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
2/3(subretinal inflammation) |
References |
PMID:
32094925
|
|
Cohort6: dose level 6
|
Administration route |
subretinal injection |
Dosage |
5E12 gp/ml |
Pts |
3 |
Age |
Child, Adult, Older_Adult |
Adverse reactions |
3/3(subretinal inflammation; Ocular pain; Suture granuloma; Anterior uveitis) |
References |
PMID:
32094925
|
|